EU-OPENSCREEN welcomes Philip Gribbon as its new Director General

EU-OPENSCREEN is pleased to announce that Philip Gribbon has been appointed as its Director General and wishes him well in his new role. Philip is known to many in our community for his time as EU-OPENSCREEN project coordinator during the latter part of the organisation’s preparatory stage. Along with Ronald Frank and many others, Philip helped to establish EU-OPENSCREEN as the leading European research infrastructure in chemical biology and supported it to the legal designation of European Research Infrastructure Consortium (ERIC) in 2018.

Currently, Philip is Head of Discovery Research at the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) in Hamburg, where he leads several activities in data-driven target validation and early drug discovery. He is involved in Fraunhofer’s programmes on targeted protein degradation and informatics initiatives for FAIR data and the application of machine learning methods to drug discovery and development (

In a 30-year professional career spent in academia, pharma, biotech, and not-for-profit research, Philip has contributed to academic and industrial programmes across many areas, from screening infrastructure technology development to drug discovery for rare diseases. EU-OPENSCREEN will benefit from his experience gained in the successful implementation of relevant EU and national projects, such as IDERHA, REMEDI4ALL, PROXIDRUGS, COMBINE, GNA-NOW, E4C, FAIRPLUS, EU-OS-DRIVE, EOSC-LIFE, EOSC-FUTURE, and ISIDORe. In addition to his day-to-day responsibilities, Philip also serves as vice president of the Society of Lab Automation and Screening (SLAS). 
We believe Philip’s leadership will be instrumental in achieving EU-OPENSCREEN's mission and fostering collaborations within the life sciences community and beyond.